Duodenal Diseases

1.	Sakata, Mikijyu: 1 article (04/2008)
2.	Nakamura, Masakatsu: 1 article (04/2008)
3.	Shibata, Tomoyuki: 1 article (04/2008)
4.	Hirata, Ichiro: 1 article (04/2008)
5.	Tahara, Tomomitsu: 1 article (04/2008)
6.	Wang, Fangyu: 1 article (04/2008)
7.	Nakano, Hiroshi: 1 article (04/2008)
8.	Arisawa, Tomiyasu: 1 article (04/2008)
9.	Serebrova, S Iu: 1 article (01/2007)
10.	Spigelman, A: 1 article (02/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Duodenal Diseases:

1.	Cimetidine (Biomet)FDA LinkGeneric 09/01/1981 - "Reflexion on cimetidine use to treat oesogastro-duodenal diseases (author's transl)]" 10/01/1979 - "Both cimetidine and antacids produced a near elimination of duodenal disease and markedly reduced the severity of gastric disease when compared to that of untreated historical controls" Order ALL the reference details at left...
2.	AntacidsIBA 10/01/1979 - "Both cimetidine and antacids produced a near elimination of duodenal disease and markedly reduced the severity of gastric disease when compared to that of untreated historical controls" Order ALL the reference details at left...
3.	rabeprazole (Aciphex)FDA Link 01/01/2007 - "The clinical effectiveness of rabeprazole in patients with acid-related gastric and duodenal diseases with various sensitivity of different types of parietal gastric cell receptors]" 05/01/1998 - "Rabeprazole, a new proton pump inhibitor, was studied in patients with acid-peptic-related diseases (duodenal ulcer, gastric ulcer, GERD) in three placebo-controlled, double-blind, randomized clinical trials" Order ALL the reference details at left...
4.	Proton Pumps (Proton Pump)IBA 05/01/1998 - "Rabeprazole, a new proton pump inhibitor, was studied in patients with acid-peptic-related diseases (duodenal ulcer, gastric ulcer, GERD) in three placebo-controlled, double-blind, randomized clinical trials" Order ALL the reference details at left...
5.	Muramidase (Lysozyme)IBA 11/01/1987 - "In order to study the lysozyme activity in the cystic mucosal and submucosal glands in the stomal area of the gastric remnant, which is one of the components of gastritis cystica polyposa, we carried out a pathological and immunohistochemical examination of 55 patients with gastric remnants, including 19 with stomal carcinoma, after partial gastrectomy for benign gastro-duodenal diseases" Order ALL the reference details at left...
6.	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/01/2002 - "We aimed to study the possible correlation between erosive oesophageal and gastro-duodenal diseases in patients with or without erosive oesophagitis who are taking low-dose aspirin, or simple analgesics, or those infected with" Order ALL the reference details at left...
7.	Analgesics (Analgesic Drugs)IBA 12/01/2002 - "We aimed to study the possible correlation between erosive oesophageal and gastro-duodenal diseases in patients with or without erosive oesophagitis who are taking low-dose aspirin, or simple analgesics, or those infected with" Order ALL the reference details at left...
8.	Pepsinogen A (Pepsinogen)IBA 11/01/1995 - "Serum pepsinogen response to therapy for Helicobacter pylori associated gastro-duodenal disease]" 10/01/1983 - "In order to evaluate its clinical usefulness, serum pepsinogen I level was measured in a prospective study in unselected patients affected by endoscopically and histologically confirmed gastric or duodenal diseases" 02/01/1983 - "Clinical significance of serum group I pepsinogen level in gastric duodenal diseases]" Order ALL the reference details at left...
9.	Omeprazole (Esomeprazole)FDA LinkGeneric 11/01/1999 - "Indications and use of omeprazole in esophago-gastro-duodenal diseases]" 11/01/2003 - "OBJECTIVE: To compare and quantify intravenous omeprazole versus intravenous pantoprazole prescription habits in common acid-related diseases such as gastro-esophageal reflux disease, duodenal ulcer, and gastric ulcer" 03/01/1994 - "Thirty-five consecutive patients (median age: 50 years, 17 men and 18 women) suffering from Helicobacter pylori associated peptic ulcer disease (duodenal ulcer: n = 15, gastric ulcer: n = 13) or severe functional dyspepsia (n = 7) were enrolled in a two-center clinical trial and treated with omeprazole 20 mg bid preprandially and roxithromycin 300 mg bid postprandially over two weeks" Order ALL the reference details at left...
10.	GastrinsIBA 05/01/1996 - "These findings showed serum gastrin levels, H.-pylori-infection, gastritis and duodenal disease in the uremic patients to be higher than those of the control group" 12/01/1976 - "Fasting and after meals serum gastrin levels were determined in healthy subjects and patients with different gastroenterological diseases (duodenal and gastric ulcer, hiatal hernia with gastroesophageal reflux, Billroth II gastric resection, atrophic gastritis, Zollinger-Ellison, Ménétrier, chronic calcifying pancreatitis, gastric carcinoma and lymphoma)" 03/01/1989 - "The content of gastrin, beta-endorphin, insulin, C-peptide in 129 patients with chronic gastric and duodenal diseases was studied by standard radioimmunoassay during the acute phase of the disease and after routine treatment" Order ALL the reference details at left...

Therapies and Procedures

1.	Gastrectomy 01/01/1989 - "Sixteen gastrectomies (25%) were necessary because of the severity of the duodenal disease with a significantly higher rate in the case of post-bulbar ulcers" 05/01/2000 - "METHODOLOGY: The study was performed in 172 patients: with gastric and duodenal ulcer, after Billroth I and Billroth II gastrectomy, with gastroesophageal reflux, after cholecystectomy, with chronic cholecystitis and chronic duodenal disease" 01/01/1997 - "The study was performed in 172 patients: with gastric and duodenal ulcer, after Billroth I and Billroth II gastrectomy, with gastroesophageal reflux, after cholecystectomy, with chronic cholecystitis and chronic duodenal disease" 11/01/1987 - "In order to study the lysozyme activity in the cystic mucosal and submucosal glands in the stomal area of the gastric remnant, which is one of the components of gastritis cystica polyposa, we carried out a pathological and immunohistochemical examination of 55 patients with gastric remnants, including 19 with stomal carcinoma, after partial gastrectomy for benign gastro-duodenal diseases" Order ALL the reference details at left...
2.	Gastroenterostomy 06/01/1988 - "A follow up was performed in 109 patients primarily undergone Billroth II resection for benign gastric or duodenal diseases to analyze mucosal changes, possibility of premalignant lesions and importance of causal factors in aetiology of gastric stump cancer" 05/01/2000 - "METHODOLOGY: The study was performed in 172 patients: with gastric and duodenal ulcer, after Billroth I and Billroth II gastrectomy, with gastroesophageal reflux, after cholecystectomy, with chronic cholecystitis and chronic duodenal disease" 01/01/1997 - "The study was performed in 172 patients: with gastric and duodenal ulcer, after Billroth I and Billroth II gastrectomy, with gastroesophageal reflux, after cholecystectomy, with chronic cholecystitis and chronic duodenal disease" 12/01/1976 - "Fasting and after meals serum gastrin levels were determined in healthy subjects and patients with different gastroenterological diseases (duodenal and gastric ulcer, hiatal hernia with gastroesophageal reflux, Billroth II gastric resection, atrophic gastritis, Zollinger-Ellison, Ménétrier, chronic calcifying pancreatitis, gastric carcinoma and lymphoma)" Order ALL the reference details at left...
3.	Cholecystectomy 05/01/2000 - "METHODOLOGY: The study was performed in 172 patients: with gastric and duodenal ulcer, after Billroth I and Billroth II gastrectomy, with gastroesophageal reflux, after cholecystectomy, with chronic cholecystitis and chronic duodenal disease" 01/01/1997 - "The study was performed in 172 patients: with gastric and duodenal ulcer, after Billroth I and Billroth II gastrectomy, with gastroesophageal reflux, after cholecystectomy, with chronic cholecystitis and chronic duodenal disease" Order ALL the reference details at left...
4.	Endoscopes 11/26/1979 - "Endoscope is the best means for the study and diagnosis of duodenal disease" Order ALL the reference details at left...
5.	Pancreaticoduodenectomy 02/01/2005 - "Pylorus-preserving pancreaticoduodenectomy for advanced duodenal disease in familial adenomatous polyposis (Br J Surg 2004; 91: 1157-1164)." 09/01/2004 - "Pylorus-preserving pancreaticoduodenectomy for advanced duodenal disease in familial adenomatous polyposis." Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Duodenal Diseases

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 1 Outcomes
Top 200 Key Drugs and Biologics
Top 13 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>